Cargando…
The Phage Lysin PlySs2 Decolonizes Streptococcus suis from Murine Intranasal Mucosa
Streptococcus suis infects pigs worldwide and may be zoonotically transmitted to humans with a mortality rate of up to 20%. S. suis has been shown to develop in vitro resistance to the two leading drugs of choice, penicillin and gentamicin. Because of this, we have pursued an alternative therapy to...
Autores principales: | Gilmer, Daniel B., Schmitz, Jonathan E., Thandar, Mya, Euler, Chad W., Fischetti, Vincent A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207509/ https://www.ncbi.nlm.nih.gov/pubmed/28046082 http://dx.doi.org/10.1371/journal.pone.0169180 |
Ejemplares similares
-
Characterization of the Bacteriophage-Derived Endolysins PlySs2 and PlySs9 with In Vitro Lytic Activity against Bovine Mastitis Streptococcus uberis
por: Vander Elst, Niels, et al.
Publicado: (2020) -
Application of the Phage Lysin Ply5218 in the Treatment of Streptococcus suis Infection in Piglets
por: Wang, Zhaofei, et al.
Publicado: (2019) -
Therapeutic potential of Bacillus phage lysin PlyB in ocular infections
por: Mursalin, Md Huzzatul, et al.
Publicado: (2023) -
Dynamic Motion and Communication in the Streptococcal C1 Phage Lysin, PlyC
por: Riley, Blake T., et al.
Publicado: (2015) -
In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria
por: Larpin, Yu, et al.
Publicado: (2018)